Age: 27
Free Agency: 2027 (UFA)
Accrued Seasons: 4
- Height: 6'5"
- Weight: 321
- College: Michigan
- Entry: 2020 Draft, Round 6, #192 overall (Packers)
- 2024 Salary Cap Charge: $6,500,000 (2.50% of cap)
- 2024 Cash Payout: $11,500,000 (4.41% of spending)
- 2024 Cash to Cap Ratio: 1.77
- Contract Value: $30,000,000 ($10,000,000 APY)
- Fully Guaranteed Money: $17,000,000
- Contract Ranking: 9/92 at LG
Current Contract
(UFA, signed 2024)
(📝: indicates contract trigger occuring during that year)| Year | Age | Base Salary | Prorated Signing Bonus | Workout Bonus | Guaranteed Salary | Cap Number | Cap % | Dead Money & Cap Savings | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 27 | $3,750,000 | $2,500,000 | $250,000 | $3,750,000 | $6,500,000 | 2.5% | |||||
| 2025 | 28 | $9,000,000 | $2,500,000 | $250,000 | $5,750,000 | $11,750,000 | 4.5% | |||||
| 2026 | 29 | $9,000,000 | $2,500,000 | $250,000 | $0 | $11,750,000 | 4.1% | |||||
| Total | $21,750,000 | $7,500,000 | $750,000 | $9,500,000 | $30,000,000 | |||||||
Contract Notes
Jon Runyan signed a three year, $30 million contract with the Giants. $17 million is guaranteed including a $7.5 million signing bonus/
Cash Flows
| 2024 | 2025 | 2026 | |
|---|---|---|---|
| Cash Due | $11,500,000 | $9,250,000 | $9,250,000 |
| Running Cash | $11,500,000 | $20,750,000 | $30,000,000 |
Career Earnings: $12,702,680
Career APY: $3,175,670
Contract History
| Team | Contract Type | Status | Year Signed | Yrs | Total | APY | Guarantees | Amount Earned | % Earned | Effective APY |
|---|---|---|---|---|---|---|---|---|---|---|
| Packers | Drafted | Expired | 2020 | 4 | $3,469,680 | $867,420 | $174,680 | $5,202,680 | 149.9% | $1,300,670 |
| Giants | UFA | Active | 2024 | 3 | $30,000,000 | $10,000,000 | $17,000,000 | $7,500,000 | 25.0% | $0 |
Earnings By Team
| Team | Yrs | Salary | APY | Paid on Cap | % Paid on Cap | Paid as Dead Money | % Paid as Dead Money |
|---|---|---|---|---|---|---|---|
| Packers | 4 | $5,202,680 | $1,300,670 | $5,202,680 | 0.0% | $0 | 0.0% |
| Giants | 0 | $7,500,000 | $0 | $0 | 0.0% | $0 | 0.0% |
Season History
| Year | Team | Base Salary | Prorated Bonus | Workout Bonus | Guaranteed Salary | Cap Number | Cap % | Cash Paid | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | Packers | $610,000 | $43,670 | $0 | $0 | $653,670 | 0.3% | $784,680 | ||
| 2021 | Packers | $780,000 | $43,670 | $0 | $0 | $823,670 | 0.4% | $780,000 | ||
| 2022 | Packers | $895,000 | $43,670 | $0 | $0 | $938,670 | 0.4% | $895,000 | ||
| 2023 | Packers | $2,743,000 | $43,670 | $0 | $0 | $2,786,670 | 1.2% | $2,743,000 | ||
| 2024 | Giants | $3,750,000 | $2,500,000 | $250,000 | $3,750,000 | $6,500,000 | 2.5% | $11,500,000 | ||
| 2025 | Giants | $9,000,000 | $2,500,000 | $250,000 | $5,750,000 | $11,750,000 | 4.5% | $9,250,000 | ||
| 2026 | Giants | $9,000,000 | $2,500,000 | $250,000 | $0 | $11,750,000 | 4.1% | $9,250,000 | ||
| Total | $26,778,000 | $7,674,680 | $750,000 | $9,500,000 | $35,202,680 | $35,202,680 | ||||
Statistics
| Year | Games Played | Games Inactive | Snaps | ||
|---|---|---|---|---|---|
| Injured | Healthy | Offense | Special | ||
| 2020 | 16 | 0 | 0 | 15.4% | 18.7% |
| 2021 | 17 | 0 | 0 | 94.4% | 19.9% |
| 2022 | 17 | 0 | 0 | 96.1% | 15.4% |
| 2023 | 17 | 0 | 0 | 84.7% | 14.4% |
Valuation Diamond
The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.
| OTC Valuation | APY | |
|---|---|---|
| Regular | $5,510,000 | $10,000,000 |
| Injury Adjusted | $5,510,000 | $10,000,000 |
Weekly Valuation Trends
The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.
To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.